Press release
Urinary Tract Infection Treatment Market to Reach US$ 10 Billion by 2022
New York, January 02: Market Research Engine has published a new report titled as “Urinary Tract Infection Treatment Market: Global Industry Analysis and Forecast 2016 – 2022”How Big is the Global Urinary Tract Infection Treatment Market?
The global urinary tract infection treatment market is expected to exceed more than US$ 10 Billion by 2022; Growing at a CAGR of more than 2% in the given forecast period.
Download Free Sample Report: https://www.marketresearchengine.com/requestsample/urinary-tract-infection-treatment-market
Urinary tract infection (UTI) arises in the kidneys, ureter, urethra and bladder because of microbial pathogens in these parts. Urinary tract infections will be uncomplicated or complicated depends on the severity of infection. The penicillin antibiotic that is amoxicillin is used to treat urinary tract infections and it is mainly used as prescribed antibiotic for uncomplicated urinary tract infection. UTI is common bacterial infections affecting many of peoples globally. Continuing urinary tract infection is a main health problem in females worldwide. Patients with spinal cord injury or urinary catheter are mainly contract complicated urinary tract infections.
The urinary tract infection treatment market is segmented on the lines of its drug type, indication, distribution channel and regional. Based on drug type segmentation it covers sulphonamides, azoles and amphotericin B, tetracycline, nitrofurans, aminoglycoside antibiotics, cephalosporin, quinolones and penicillin & combinations. Aminoglycoside antibiotics is further segmented into amikacin and gentamicin. Cephalosporin segmentation covers ceftriaxone, cefuroxime, cefixime and cephalexin. Under quinolones segmentation it covers ciprofloxacin, levofloxacin, nalidixic acid, norfloxacin and others. Penicillin and combinations covers amoxicillin, amoxicillin & clavulanate potassium and others.
The urinary tract infection treatment market is segmented on the lines of its indication like into complicated UTI, recurring complicated UTI, uncomplicated UTI and neurogenic bladder infections. Under distribution channel segmentation it covers hospital pharmacies, gynaecology and urology clinics, drug store, retail pharmacies and online drug stores. The urinary tract infection treatment market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for urinary tract infection treatment and related technologies.
2) Analysis of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for urinary tract infection treatment.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Browse Full Report: https://www.marketresearchengine.com/reportdetails/urinary-tract-infection-treatment-market
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Urinary Tract Infection Treatment Market for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Johnson and Johnsons Private Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., Bayer AG, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Inc., F.Hoffmann-La Roche Ltd., Novartis AG. and AstraZeneca plc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Urinary Tract Infection Treatment Market has been segmented as below:
By Drug Type Analysis
• Sulphonamides
• Azoles and Amphotericin B
• Tetracycline
• Nitrofurans
• Aminoglycoside antibiotics
o Amikacin
o Gentamicin
• Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
• Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
• Penicillin & Combinations
Amoxicillin
Amoxicillin & Clavulanate Potassium
Others
By Indication Analysis
• Complicated UTI
• Recurring Complicated UTI
• Uncomplicated UTI
• Neurogenic Bladder Infections
By Distribution channel Analysis
• Hospital Pharmacies
• Gynaecology and Urology Clinics
• Drug Store
• Retail Pharmacies
• Online Drug Stores
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urinary Tract Infection Treatment Market to Reach US$ 10 Billion by 2022 here
News-ID: 404130 • Views: …
More Releases from MRE
Exoskeleton Market is Worth US$ 2.5 Billion by 2024
New York, June 25, 2018: An exoskeleton is that the external skeleton that supports and protects an animal's body, in contrast to the interior skeleton (endoskeleton) of, for instance, a human. In usage, a number of the larger varieties of exoskeletons are called "shells".
The scope of the report includes a detailed study of Exoskeleton Market with the reasons given for variations in the growth of the industry in…
Electric Motors Market to Reach US$ 130 Billion Globally by 2020
The electric motor market is segmented on the lines of its type, application and output power. The electric motor market is segmented on the lines of its type like alternating current (AC) motor, direct current (DC) motor and hermetic motors. The alternating current motor is further segmented into synchronous alternating current motor and induction alternating current motor. Under direct current motor segmentation it covered brushed direct current motor and brushless…
Medical Tourism Market is Expected to Cross USD 54.00 Billion Globally by 2022
This market research report on the global medical tourism helps in understanding the important forces responsible for the growth of this industry. The research report provides in-depth analysis of the geographies facilitating inbound medical services that include Singapore, India, Thailand, Brazil, Malaysia, Mexico, Turkey, Taiwan, South Korea and prospective countries. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market…
Foot Orthotics Insole Market is Expected to Cross US$ 50 Billion by 2020
The Global Foot Orthotics Insole Market is segmented on the lines of its product, service, type and regional. Based on product segmentation it covers the type of material that is used are Nylon, EVA form, Leather, polypropylene and others. It’s also segmented on the end users such as sports, medical and comfort. Further in medical it is segmented on various diseases like diabetes, obesity, rheumatoid arthritis and others.
Browse Full Report…
More Releases for UTI
Urinary Tract Infection (UTI) Treatment Market Expanding Solutions for Rising Gl …
Introduction
The urinary tract infection (UTI) treatment market is witnessing significant growth, driven by the increasing prevalence of UTIs globally, rising awareness of treatment options, and advances in medical technologies. UTIs affect millions of individuals each year, with women being disproportionately impacted. As antibiotic resistance becomes an increasing concern and healthcare providers explore alternative solutions, the market for UTI treatments continues to evolve.
This article explores the key factors driving the…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction
Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by…
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHL…
Investigation for Investors in shares of Patterson-UTI Energy, Inc. (NASDAQ: PTE …
An investigation was announced concnering potential breaches of fiduciary duties by certain directors at Patterson-UTI Energy, Inc.
Investors who purchased shares of Patterson-UTI Energy, Inc. (NASDAQ: PTEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Patterson-UTI Energy directors breached their fiduciary duties and caused damage to the company and its shareholders.
Houston, TX based Patterson-UTI…
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report:
The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals…
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract…
